TNF and inflammatory bowel disease: Current pharmacological treatment for IBD mainly includes 5-aminosalicylate, corticosteroids, anti-TNF (tumor necrosis factor) drugs (infliximab (IFX), adalimumab (ADA)), anti-integrin preparation (vedolizumab (VDZ)) [49–53], all of which may reduce the occurrence of infectious complications to some extent.